Skip to main content
OpenTrials
Completed

NCT Number: NCT04804995

Investigating the Frequency and Phenotype of Headaches Associated With Fasting During the Month of Ramadan.

Headaches are more common in the month of Ramadan in patients who already suffer from migraine. The object of the present study is investigate the frequency in the Ramadan month .

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Danish Headache Center

Glostrup Municipality, 2600, Denmark

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age 18-60 years.
  • expectation of fasting for at least 21 of 30 days during the month of Ramadan.
  • understand and answer the questionnaire sent out in Danish.

Exclusion criteria

  • non-compliance with the headache calendar (defined as non-registration of at least 21 days per 30 days).

Treatment and study plan

There is no intervention.

Other

No intervention.

Primary outcomes

  1. Headache frequency

    Time frame: Daily headache diary in three months.

    The frequency of headaches is higher in the first half of Ramadan month compared to the last half.

  2. Headache frequency

    Time frame: Daily headache diary in three months.

    The frequency of headaches is higher in the month before Ramadan compared to the month after ramadan.

Sponsors and collaborators

Lead sponsor

Danish Headache Center

Other

Registry information

Official study title

Headache in Ramadan.

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Mar 18, 2021
Registry last updated
Nov 16, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.